VIEDOC
Viedoc develops cloud-based electronic data capture and clinical trial management software used by pharmaceutical, biotech, and medical device companies as well as contract research organizations to design, run, and monitor clinical studies. Its platform supports electronic case report forms, ePRO/eCOA, randomization, and trial oversight to streamline data collection and regulatory-compliant trial operations. Viedoc generates revenue through subscription and service fees for its SaaS platform and related implementation and support services.
- Clinical Trial & Research Software
- Revenue
- $35.0M
- Employees
- 200
- Founded
- 2003
- Headquarters
- Uppsala, Sweden
What 5 Arbolus experts think of VIEDOC
5 customers have reviewed VIEDOC so far. The full customer report is in progress and publishes once enough customers have been interviewed in depth.
Who reviewed VIEDOC
- C-Suite 25% (1)
- Director 50% (3)
- Manager 25% (1)
Employer names and spend open once the report publishes.
Tell us when the VIEDOC report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
20 Net Promoter Score, from 5 scored reviews- Promoters 2
- Passives 2
- Detractors 1
Cumulative NPS by month
-1 over 5 months- Feb 9
- Apr 8
- Jun 8
- Jul 8
- Aug 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 20 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 33%Plan to renew, by seniority
- 100% 1 answer
- 0% 2 answers
- 10/10 Average score from customers who will renew
- 6.5/10 Average score from undecided customers
More in Data & Analytics
Other companies in Data & Analytics with a customer report.
For people who use VIEDOC
Do you use VIEDOC at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 5 customers of VIEDOC have already contributed
Takes a few minutes. Your identity stays anonymous.